Home > Healthcare > Biotechnology > Bioservices > Cell & Gene Therapy Manufacturing Services Market
Increasing investments in cell and gene therapy, adoption of automation and digitalization to meet the growing demand for cell and gene therapy manufacturing services, and expansion of manufacturing capacity is beneficial for the market growth. There is a growing demand for cell and gene therapies, and this has led to an expansion of manufacturing capacity. Biopharmaceutical companies are investing in new manufacturing facilities, expanding existing facilities, and partnering with contract manufacturing organisations (CMOs) to meet the increasing demand for these therapies.